Overcoming imatinib resistance using Src inhibitor CGP76030, Abl inhibitor nilotinib and Abl/Lyn inhibitor INNO‐406 in newly established K562 variants with <i>BCR‐ABL</i> gene amplification

Koji Morinaga(University of Fukui), Takanori Ueda(University of Fukui)

International Journal of Cancer

March 13, 2008

10.1002/ijc.23435

Cited by 40

Related Papers

Glutathione S‐transferase M1 inhibits dexamethasone‐induced apoptosis in association with the suppression of Bim through dual mechanisms in a lymphoblastic leukemia cell line

|Cancer Science|2009|26

Combination of guanine arabinoside and Bcl‐2 inhibitor <scp>YC</scp>137 overcomes the cytarabine resistance in <scp>HL</scp>‐60 leukemia cell line

|Cancer Science|2013|11